We have located links that may give you full text access.
Nutritional Intervention in Cushing's Disease: The Ketogenic Diet's Effects on Metabolic Comorbidities and Adrenal Steroids.
Nutrients 2023 November 3
BACKGROUND: a very low-calorie ketogenic diet (VLCKD) is associated with improvement of metabolic and cardiovascular disorders. We aimed to evaluate the effects of a VLCKD in patients with Cushing's disease (CD) as adjunctive therapy to treatment for the primary disease.
METHODS: we evaluated clinical, hormonal and metabolic parameters in 15 patients with CD and 15 controls at baseline after 1 week and 3 weeks of VLCKD and, further, after 2 weeks of a low-carbohydrate ketogenic diet (LCKD).
RESULTS: after 5 weeks of diet, a significant decrease in BMI ( p = 0.002), waist circumference (WC) ( p = 0.024), systolic blood pressure ( p = 0.015), diastolic blood pressure ( p = 0.005), ACTH ( p = 0.026), cortisone ( p = 0.025), total cholesterol ( p = 0.006), LDL cholesterol ( p = 0.017), triglycerides ( p = 0.016) and alkaline phosphatase ( p = 0.008) and a significant increase in HDL cholesterol ( p = 0.017), vitamin D ( p = 0.015) and oral disposition index (oDI) ( p = 0.004) was observed in the CD patients. A significant decrease in BMI ( p = 0.003), WC ( p = 0.002), systolic blood pressure ( p = 0.025), diastolic ( p = 0.007) blood pressure and total cholesterol ( p = 0.026) and an increase in HDL cholesterol ( p = 0.001) and oDI ( p < 0.001) was observed in controls.
CONCLUSIONS: the current study confirms that a ketogenic diet is effective in improving metabolic disorders in CD and shows that a nutritional approach may be combined with conventional CD therapy in order to improve metabolic and cardiovascular comorbidities.
METHODS: we evaluated clinical, hormonal and metabolic parameters in 15 patients with CD and 15 controls at baseline after 1 week and 3 weeks of VLCKD and, further, after 2 weeks of a low-carbohydrate ketogenic diet (LCKD).
RESULTS: after 5 weeks of diet, a significant decrease in BMI ( p = 0.002), waist circumference (WC) ( p = 0.024), systolic blood pressure ( p = 0.015), diastolic blood pressure ( p = 0.005), ACTH ( p = 0.026), cortisone ( p = 0.025), total cholesterol ( p = 0.006), LDL cholesterol ( p = 0.017), triglycerides ( p = 0.016) and alkaline phosphatase ( p = 0.008) and a significant increase in HDL cholesterol ( p = 0.017), vitamin D ( p = 0.015) and oral disposition index (oDI) ( p = 0.004) was observed in the CD patients. A significant decrease in BMI ( p = 0.003), WC ( p = 0.002), systolic blood pressure ( p = 0.025), diastolic ( p = 0.007) blood pressure and total cholesterol ( p = 0.026) and an increase in HDL cholesterol ( p = 0.001) and oDI ( p < 0.001) was observed in controls.
CONCLUSIONS: the current study confirms that a ketogenic diet is effective in improving metabolic disorders in CD and shows that a nutritional approach may be combined with conventional CD therapy in order to improve metabolic and cardiovascular comorbidities.
Full text links
Related Resources
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app
All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.
By using this service, you agree to our terms of use and privacy policy.
Your Privacy Choices
You can now claim free CME credits for this literature searchClaim now
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app